A human trial of a hepatitis C treatment is shut down after one of the participants died.
Advertisement
The Scientist
Most Recent
Another person has died from the rodent-borne disease after visiting Yosemite National Park.
Researchers consider the recent reappearance of West Nile virus in Texas and the efforts to control it.
Mice with inflammatory bowel disease harbor gut bacteria that damage host DNA, predisposing mice to cancer.
Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.
Submit your cutting-edge product to The Scientist Top Ten Innovations of 2012 contest and see which ones win!
The first full computer model of a single-celled organism mimics the bacterium’s behaviors and paves the way to more complete disease models.
Rather than rely on plant-derived products, biotech companies are engineering bacteria and yeast to produce ingredients for fragrances.
The recently hyped amoeba-flagellate Collodictyon has many secrets to tell about early eukaryotic evolution.
New changes at The Scientist will ensure that we continue to showcase the best and brightest ideas in the life sciences.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
